US Broker Ratings

Perrigo Company plc (PRGO): Exploring a 55% Upside Potential Amidst High Dividend Yields

Perrigo Company plc (NYSE: PRGO), a stalwart in the healthcare sector, stands as a prominent player in the drug manufacturers industry, focusing on specialty and generic medications. Headquartered in Dublin,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a $10 Billion Valuation and Strategic Growth in Genetic Medicine

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning player in the biotechnology sector, is capturing investor interest with its strategic focus on genetic medicines targeting diseases with high unmet medical needs...

Guardant Health, Inc. (GH) Stock Analysis: Unpacking a 48% Revenue Growth in the Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH) has emerged as a formidable player in the diagnostics and research segment of the healthcare industry. With a market capitalization of $20.67 billion, this precision..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 33.81% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, has been a topic of interest among investors due to its extensive range of over-the-counter (OTC) health..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth with a 15.59% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically within the drug manufacturing industry for specialty and generic products, presents an intriguing opportunity for investors..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a Potential 11.54% Upside

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare industry, primarily focuses on medical instruments and supplies, particularly within the eye health sector. With a market capitalization of..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 23.48% ROE in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector known for its diagnostic and therapeutic innovations, presents an intriguing prospect for investors keen on the drug manufacturing..

TG Therapeutics, Inc. (TGTX): Investor Outlook on a Biotech Powerhouse with 6.39% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a significant player in the biotechnology sector, boasting a market capitalization of $8.4 billion. Renowned for its innovative approach in the healthcare industry,..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 22.65% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, has been capturing investor attention with its promising pipeline and robust market performance. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential Amidst a 12.36% Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, operates as a leading pharmaceutical entity within the specialty and generic drug manufacturing industry. Headquartered in Hyderabad,..

Waystar Holding Corp. (WAY) Stock Analysis: Strong Buy Ratings and a Promising 50% Upside Potential

For investors seeking opportunities in the healthcare sector, Waystar Holding Corp. (WAY) presents an intriguing proposition. With its focus on developing innovative cloud-based software solutions for healthcare payments, Waystar stands..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Potential 54% Upside in Cutting-Edge Organ Care

TransMedics Group, Inc. (NASDAQ: TMDX), a pioneer in the healthcare sector specializing in medical devices, is making significant strides in transforming organ transplant therapy. With a market capitalization of $2.56..

BrightSpring Health Services (BTSG): Growth Potential in Healthcare with a 7.51% Upside

BrightSpring Health Services, Inc. (BTSG) stands out in the healthcare sector as a formidable player in the Health Information Services industry. With a market capitalization of $13.87 billion, BrightSpring is..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.24 billion, this Plano, Texas-based..

Nuvalent Inc. (NUVL) Stock Analysis: Examining the Biotech’s Strategic Growth and Analyst Ratings

For investors keen on the biotechnology sector, Nuvalent, Inc. (NASDAQ: NUVL) presents a compelling case with its focus on developing innovative cancer therapies. The company, based in Cambridge, Massachusetts, operates..

Alkermes plc (ALKS) Stock Analysis: A Rising Star in the Biopharma Sector with 28.20% Revenue Growth

Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical industry, has been turning heads with its impressive financial performance and strategic focus on addressing unmet medical needs. As investors..

Qiagen N.V. (QGEN) Stock Analysis: Evaluating the 7.09% Upside Potential for Investors

For investors seeking opportunities in the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents a compelling case with its robust presence in the diagnostics and research industry. Headquartered in Venlo, Netherlands,..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 28.77% Potential Upside for Investors

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, is capturing investor interest with its innovative approach to treating rare genetic diseases. With a current market capitalization..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Strong Analyst Support and 34% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating debilitating diseases through muscle activators and inhibitors...

Genmab A/S (GMAB) Stock Analysis: Investor Optimism with a 28.55% Potential Upside

Genmab A/S (GMAB) is a pivotal player in the biotechnology sector, commanding significant attention with its innovative antibody-based treatments for cancer and other serious diseases. Headquartered in Copenhagen, Denmark, Genmab..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds